• Explore /
  • Poster
  • / Phase 3 study evaluating efficacy and safety of veliparib (V) plus carboplatin (Cb) or Cb in combination with standard neoadjuvant chemotherapy (NAC) in patients (pts) with early stage triple-negative breast cancer (TNBC).

Phase 3 study evaluating efficacy and safety of veliparib (V) plus carboplatin (Cb) or Cb in combination with standard neoadjuvant chemotherapy (NAC) in patients (pts) with early stage triple-negative breast cancer (TNBC).

Abstract Poster

Authors

Charles Geyer, Jr

Charles E. Geyer Jr.

Virginia Commonwealth University Massey Cancer Center, Richmond, VA

Charles E. Geyer Jr., Joyce O'Shaughnessy , Michael Untch , William Sikov , Hope S. Rugo , Mark D. McKee , Jens Bodo Huober , Mehra Golshan , Vincent L. Giranda , Gunter Von Minckwitz , David Maag , Danielle Marie Sullivan , Norman Wolmark , Kristi McIntyre , Jose Juan Ponce Lorenzo , Otto Metzger Filho , Priya Rastogi , William Fraser Symmans , Xuan Liu , Sibylle Loibl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Clinical Trial Registration Number

NCT02032277

Citation

J Clin Oncol 35, 2017 (suppl; abstr 520)

DOI

10.1200/JCO.2017.35.15_suppl.520

Abstract #

520

Poster Bd #

120

Abstract Disclosures

Similar Posters

First Author: Gunter Von Minckwitz

First Author: Peter Schmid

First Author: Tiffany P. Avery

First Author: Jeremy Meyer Force